Fig. 3From: Standardization of double blind placebo controlled food challenge with soy within a multicentre trialSubjective symptoms at lowest subjective symptom dose to soy and to placebo challenge meals. 138 subjects underwent DBPCFC, 82/138 wereDBPCFC+. Intraoral, tingling/itching; lip, swelling; itch, skin/eye/nose; abd., abdominalBack to article page